2020
DOI: 10.2147/ott.s276837
|View full text |Cite
|
Sign up to set email alerts
|

<p>In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration</p>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…At the molecular level, the effect was achieved by downregulating EGFR and blocking the interaction of Sp1 and HADC1 [ 102 ]. More recently, the increased efficacy of this treatment in this cancer has been reported through the use of a liposome-based co-delivery system [ 107 ].…”
Section: The Combination Of Curcumin and Chemotherapy Drugs In Cancer...mentioning
confidence: 99%
“…At the molecular level, the effect was achieved by downregulating EGFR and blocking the interaction of Sp1 and HADC1 [ 102 ]. More recently, the increased efficacy of this treatment in this cancer has been reported through the use of a liposome-based co-delivery system [ 107 ].…”
Section: The Combination Of Curcumin and Chemotherapy Drugs In Cancer...mentioning
confidence: 99%
“…Co-delivery is the delivery of two substances with different functions together to achieve synergistic effects. Zhou et al reported the co-delivery of gefitinib (GFT) and curcumin loaded in liposomes with PEGylated phospholipids and soybean phosphatidylcholine (PC) [57]. GFT is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase activity in diverse tumors.…”
Section: Liposomes and Phytosomesmentioning
confidence: 99%